Hippocampal synaptic plasticity is impaired in the Mecp2-null mouse model of Rett syndrome

Neurobiology of Disease

Volumn 21, Issue 1, 2006, Pages 217-227

  Asaka, Yukiko ^a   Jugloff, Denis G M ^b   Zhang, Liang ^b   Eubanks, James H ^b   Fitzsimonds, Reiko Maki ^a  

^a YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF TORONTO   (Canada)

Author keywords

LTD; LTP; Mental retardation

Indexed keywords

BETA TUBULIN; CYTOSKELETON PROTEIN; GLUTAMATE RECEPTOR 1; GLUTAMATE RECEPTOR 2; METHYL CPG BINDING PROTEIN 2; MICROTUBULE ASSOCIATED PROTEIN 2; N METHYL DEXTRO ASPARTIC ACID RECEPTOR; N METHYL DEXTRO ASPARTIC ACID RECEPTOR 2A; N METHYL DEXTRO ASPARTIC ACID RECEPTOR 2B; POSTSYNAPTIC DENSITY PROTEIN 95; RECEPTOR SUBUNIT; SYNAPTOBREVIN 2; SYNAPTOPHYSIN; SYNAPTOTAGMIN; TRANSCRIPTION FACTOR; TRANSCRIPTION FACTOR NF200; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; COGNITIVE DEFECT; CONTROLLED STUDY; HIPPOCAMPUS; HIPPOCAMPUS THETA RHYTHM; IMMUNOBLOTTING; LONG TERM DEPRESSION; LONG TERM POTENTIATION; MENTAL DEFICIENCY; MOUSE; NERVE CELL PLASTICITY; NEUROTRANSMISSION; NONHUMAN; PRESYNAPTIC POTENTIAL; PRIORITY JOURNAL; PROTEIN EXPRESSION; RETT SYNDROME;

ANIMALS; CYTOSKELETAL PROTEINS; DISEASE MODELS, ANIMAL; EXCITATORY POSTSYNAPTIC POTENTIALS; HIPPOCAMPUS; LONG-TERM POTENTIATION; METHYL-CPG-BINDING PROTEIN 2; MICE; MICE, INBRED C57BL; MICE, MUTANT STRAINS; NEURONAL PLASTICITY; RECEPTORS, N-METHYL-D-ASPARTATE; RETT SYNDROME; SYNAPTIC TRANSMISSION; THETA RHYTHM;

EID: 29144440149     PISSN: 09699961     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.nbd.2005.07.005     Document Type: Article

References (35)

1. R.E. Amir, I.B. Van den Veyver, M. Wan, C.Q. Tran, U. Francke, and H.Y. Zoghbi Rett syndrome is caused by mutations in X-linked MECP2, encoding methyl-CpG-binding protein 2 Nat. Genet. 23 1999 185 188
2. D.D. Armstrong Rett syndrome neuropathology review 2000 Brain Dev. 23 Suppl. 1 2001 S72 S76
3. D.D. Armstrong Neuropathology of Rett syndrome Ment. Retard. Dev. Disabil. Res. Rev. 8 2002 72 76
4. P.V. Belichenko, A. Oldfors, B. Hagberg, and A. Dahlstrom Rett syndrome: 3-D confocal microscopy of cortical pyramidal dendrites and afferents NeuroReport 5 1994 1509 1513
5. M.E. Blue, S. Naidu, and M.V. Johnston Altered development of glutamate and GABA receptors in the basal ganglia of girls with Rett syndrome Exp. Neurol. 156 1999 345 352
6. M.E. Blue, S. Naidu, and M.V. Johnston Development of amino acid receptors in frontal cortex from girls with Rett syndrome Ann. Neurol. 45 1999 541 545
7. G. Chen, R. Kolbeck, Y.A. Barde, T. Bonhoeffer, and A. Kossel Relative contribution of endogenous neurotrophins in hippocampal long-term potentiation J. Neurosci. 19 1999 7983 7990
8. R.Z. Chen, S. Akbarian, M. Tudor, and R. Jaenisch Deficiency of methyl-CpG binding protein-2 in CNS neurons results in a Rett-like phenotype in mice Nat. Genet. 27 2001 327 331
9. W.G. Chen, Q. Chang, Y. Lin, A. Meissner, A.E. West, E.C. Griffith, R. Jaenisch, and M.E. Greenberg Derepression of BDNF transcription involves calcium-dependent phosphorylation of MeCP2 Science 302 2003 885 889
10. A.L. Collins, J.M. Levenson, A.P. Vilaythong, R. Richman, D.L. Armstrong, J.L. Noebels, J.D. Sweatt, and H.Y. Zoghbi Mild overexpression of MeCP2 causes a progressive neurological disorder in mice Hum. Mol. Genet. 13 2004 2679 2689
11. S. Cull-Candy, S. Brickley, and M. Farrant NMDA receptor subunits: diversity, development and disease Curr. Opin. Neurobiol. 11 2001 327 335
12. A. Free, R.I. Wakefield, B.O. Smith, D.T. Dryden, P.N. Barlow, and A.P. Bird DNA recognition by the methyl-CpG binding domain of MeCP2 J. Biol. Chem. 276 2001 3353 3360
13. J. Guy, B. Hendrich, M. Holmes, J.E. Martin, and A. Bird A mouse Mecp2-null mutation causes neurological symptoms that mimic Rett syndrome Nat. Genet. 27 2001 322 326
14. B. Hagberg, and I. Witt-Engerstrom Rett syndrome: a suggested staging system for describing impairment profile with increasing age towards adolescence Am. J. Med. Genet., Suppl. 1 1986 47 59
15. B. Hagberg, F. Goutieres, F. Hanefeld, A. Rett, and J. Wilson Rett syndrome: criteria for inclusion and exclusion Brain Dev. 7 1985 372 373
16. A. Hamberger, C. Gillberg, A. Palm, and B. Hagberg Elevated CSF glutamate in Rett syndrome Neuropediatrics 23 1992 212 213
17. M.V. Johnston Clinical disorders of brain plasticity Brain Dev. 26 2004 73 80
18. B.P. Jung, D.G. Jugloff, G. Zhang, R. Logan, S. Brown, and J.H. Eubanks The expression of methyl CpG binding factor MeCP2 correlates with cellular differentiation in the developing rat brain and in cultured cells J. Neurobiol. 55 2003 86 96
19. H. Kang, A.A. Welcher, D. Shelton, and E.M. Schuman Neurotrophins and time: different roles for TrkB signaling in hippocampal long-term potentiation Neuron 19 1997 653 664
20. W.E. Kaufmann, S. Naidu, and S. Budden Abnormal expression of microtubule-associated protein 2 (MAP-2) in neocortex in Rett syndrome Neuropediatrics 26 1995 109 113
21. W.E. Kaufmann, C.V. Taylor, C.F. Hohmann, I.B. Sanwal, and S. Naidu Abnormalities in neuronal maturation in Rett syndrome neocortex: preliminary molecular correlates Eur. Child Adolesc. Psychiatry 6 Suppl. 1 1997 75 77
22. W.E. Kaufmann, S.M. MacDonald, and C.R. Altamura Dendritic cytoskeletal protein expression in mental retardation: an immunohistochemical study of the neocortex in Rett syndrome Cereb. Cortex. 10 2000 992 1004
23. A.H. Kossel, S.B. Cambridge, U. Wagner, and T. Bonhoeffer A caged Ab reveals an immediate/instructive effect of BDNF during hippocampal synaptic potentiation Proc. Natl. Acad. Sci. U. S. A. 98 2001 14702 14707
24. C.A. Kozinetz, M.L. Skender, N. MacNaughton, M.J. Almes, R.J. Schultz, A.K. Percy, and D.G. Glaze Epidemiology of Rett syndrome: a population-based registry Pediatrics 91 1993 445 450
25. R. Lappalainen, and R.S. Riikonen High levels of cerebrospinal fluid glutamate in Rett syndrome Pediatr. Neurol. 15 1996 213 216
26. L. Liu, T.P. Wong, M.F. Pozza, K. Lingenhoehl, Y. Wang, M. Sheng, Y.P. Auberson, and Y.T. Wang Role of NMDA receptor subtypes in governing the direction of hippocampal synaptic plasticity Science 304 2004 1021 1024
27. M.A. Lynch Long-term potentiation and memory Physiol. Rev. 84 2004 87 136
28. K. Martinowich, D. Hattori, H. Wu, S. Fouse, F. He, Y. Hu, G. Fan, and Y.E. Sun DNA methylation-related chromatin remodeling in activity-dependent BDNF gene regulation Science 302 2003 890 893
29. B.C. Mullaney, M.V. Johnston, and M.E. Blue Developmental expression of methyl-CpG binding protein 2 is dynamically regulated in the rodent brain Neuroscience 123 2004 939 949
30. X. Nan, H.H. Ng, C.A. Johnson, C.D. Laherty, B.M. Turner, R.N. Eisenman, and A. Bird Transcriptional repression by the methyl-CpG-binding protein MeCP2 involves a histone deacetylase complex Nature 393 1998 386 389
31. M.D. Shahbazian, B. Antalffy, D.L. Armstrong, and H.Y. Zoghbi Insight into Rett syndrome: MeCP2 levels display tissue- and cell-specific differences and correlate with neuronal maturation Hum. Mol. Genet. 11 2002 115 124
32. G.G. Turrigiano, and S.B. Nelson Homeostatic plasticity in the developing nervous system Nat. Rev., Neurosci. 5 2004 97 107
33. B. van Zundert, A. Yoshii, and M. Constantine-Paton Receptor compartmentalization and trafficking at glutamate synapses: a developmental proposal Trends Neurosci. 27 2004 428 437
34. A.M. Watabe, P.A. Zaki, and T.J. O'Dell Coactivation of beta-adrenergic and cholinergic receptors enhances the induction of long-term potentiation and synergistically activates mitogen-activated protein kinase in the hippocampal CA1 region J. Neurosci. 20 2000 5924 5931
35. R.S. Zucker Short-term synaptic plasticity Annu. Rev. Neurosci. 12 1989 13 31